- 1. *Time (e.g. seconds)
- [The continuum of experience in which events pass from the future through the present to the past; a specific point in this continuum or the interval separating two points. ( NCI )] (UMLS (HL7) C0040223) =Temporal Concept ;
=Kind of quantity;
| - 51. Time delay post challenge
- (UMLS (HL7) C1547661) =Temporal Concept =HL7 Vocabulary Version 2.5;
=10 minutes post challenge;
|
- 2. *Time Difference
- (UMLS (HL7) C1547049) =Quantitative Concept =Kind of quantity;
| - 52. Time from the challenge, or dose not specified. (random)
- (UMLS (HL7) C1547094) =Temporal Concept =Time delay post challenge;
|
- 3. *Time Ratio
- (UMLS (HL7) C1547051) =Temporal Concept =Kind of quantity;
| - 53. time interval
- [ ] (UMLS (CSP) C0872291) =Temporal Concept ;
|
- 4. *Time Stamp — Date and Time
- (UMLS (HL7) C1547050) =Quantitative Concept =Kind of quantity;
| - 54. time orientation
- [ ] (UMLS (CSP) C0599544) =Mental Process ;
|
- 5. C (_cum_)
- (UMLS (HL7) C1548612) =Temporal Concept =Repeat;
| - 55. time perception
- [ability to estimate periods of time lapsed or duration of time; attention to, or apprehension of, change through the integration of a series of stimuli and characterized by the ability to conceive of duration, simultaneity, and succession. ( CSP )] (UMLS (CSP) C0040226) =Mental Process ;
=perception;
|
- 6. Ti element
- [dark gray metallic element of widespread distribution but occurring in small amounts, atomic number 22, symbol Ti; used for fixation of fractures. ( CSP )] (UMLS (CSP) C0040302) =Element, Ion, or Isotope =heavy metal;
Metals, Light =Titanium Dioxide;
| - 56. Time Range
- [A range of time between a start and an end time having a duration. The range may be infinite or undefined on either side. ( HL7V3.0 )] (UMLS (HL7) C1554109) =Idea or Concept =MDFAttributeType;
|
- 7. TIAGABINE
- (UMLS (NCI) C0068897) =Organic Chemical; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
Nipecotic Acids =(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic Acid, Hydrochloride;
| - 57. time release medication
- [ ] (UMLS (CSP) C1135769) timed release drug =Pharmacologic Substance
|
- 8. TIAM1
- [TIAM1 appears to function in cellular signaling by modulating activation the GDP-GTP exchange activity of RHO-like GTPases that regulate cytoskeletal organization. The serine-rich TIAM1 protein contains a DH domain, a PDZ/DHR domain, and two PH domains. The DH domain is found in GDP-GTP exchanger proteins that activate RHO-like GTPases and PH domains are thought to be involved in protein-protein interactions. TIAM1 activates RAC1, CDC42, and to a lesser extent RHOA. (from OMIM 600687 and NCI) ( NCI )] (UMLS (NCI) C0919491) TIAM1 Protein;
T-Lymphoma Invasion and Metastatis Inducing Protein 1;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 58. time resolved data
- [studies in which time or time courses are of interest; elements of limited time intervals. ( CSP )] (UMLS (CSP) C0597585) =Intellectual Product =computer data analysis;
|
- 9. Tibetan Spaniel
- [The Tibetan Spaniel is a small dog that looks rather like a Pekingese, but with a slightly longer face, less profuse coat and no extra skin around the eyes. It has a plumed tail curled over his back, feathered pendent ears and soft, medium-length, flat coat. Height: 10 inches (51 cm.) Weight: 9-15 pounds (4.1-6.8 kg.) ( NCI )] (UMLS (NCI) C0324471) =Mammal
| - 59. Time selection criteria parameter class codes
- (UMLS (HL7) C1547695) =Intellectual Product ;
=HL7 Vocabulary Version 2.5;
=An indicator that Friday is or is not preferred for the day on which the appointment will occur.;
An indicator that Monday is or is not preferred for the day on which the appointment will occur.;
An indicator that there is a preferred end time for the appointment request, service or resource.;
An indicator that there is a preferred start time for the appointment request, service or resource.;
An indicator that Saturday is or is not preferred for the day on which the appointment will occur.;
An indicator that Sunday is or is not preferred for the day on which the appointment will occur.;
An indicator that Thursday is or is not preferred for the day on which the appointment will occur.;
An indicator that Tuesday is or is not preferred for the day on which the appointment will occur.;
An indicator that Wednesday is or is not preferred for the day on which the appointment will occur.;
|
- 10. Tibetan Terrier
- [The Tibetan Terrier is a medium-sized squarely proportioned dog that looks more like a sheepdog than a terrier. It has a fine outer coat that is straight or wavy and a soft, wooly undercoat. The coat is long, but should not touch the ground. The feathered tail is heavily furnished and carried over the back. This breed's unique, large, flat feet are well furnished with hair and produce a snowshoe effect that provides traction and flotation in snow. Height: 14-17 inches (36-43 cm.) Weight: 18-30 pounds (8.2-13.6 kg.) ( NCI )] (UMLS (NCI) C0324472) =Mammal
| - 60. Time Series Analysis
- [There are two main goals of time series analysis: (a) identifying the nature of the phenomenon represented by the sequence of observations, and (b) forecasting (predicting future values of the time series variable). ( NCI )] (UMLS (NCI) C0681939) =Research Activity
|
- 11. tibia
- [shin bone; inner and larger bone of the leg below the knee; it articulates with the femur and head of the fibula above and the talus below. ( CSP )] (UMLS (CSP) C0040184) =Body Part, Organ, or Organ Component ;
=Body Part;
Bone of Extremity | - 61. Time slots available for a recurring appointment
- (UMLS (HL7) C1546480) =Idea or Concept =What subject filter;
|
- 12. TIBIA/FIBUL WEDG OSTEOT
- [ ] (UMLS (ICD9CM) C0177338) =Therapeutic or Preventive Procedure
| - 62. Time slots available for a single appointment
- (UMLS (HL7) C1546479) =Idea or Concept =What subject filter;
|
- 13. TIBIA/FIBULA INJ OP NOS
- [ ] (UMLS (ICD9CM) C0187775) =Therapeutic or Preventive Procedure
| - 63. Time stamp
- (UMLS (HL7) C1547406) =Idea or Concept =Data type;
|
- 14. Tibial Adamantinoma
- (UMLS (NCI) C1273017) =Neoplastic Process ;
| - 64. Time Stamp (Date & Time)
- (UMLS (HL7) C1548320) =Idea or Concept =Value type;
|
- 15. Tibial Artery
- [The anterior and posterior arteries created at the bifurcation of the popliteal artery. The anterior tibial artery begins at the lower border of the popliteus muscle and lies along the tibia at the distal part of the leg to surface superficially anterior to the ankle joint. Its branches are distributed throughout the leg, ankle, and foot. The posterior tibial artery begins at the lower border of the popliteus muscle, lies behind the tibia in the lower part of its course, and is found situated between the medial malleolus and the medial process of the calcaneal tuberosity. Its branches are distributed throughout the leg and foot. ( MSH )] (UMLS (NCI) C0085427) =Body Part, Organ, or Organ Component ;
| - 65. Timing critical
- (UMLS (HL7) C1547584) =Intellectual Product =Extended Priority Codes;
|
- 16. TIBIAL COLL LIG BURSITIS
- (UMLS (ICD9CM) C0158315) =Disease or Syndrome
| - 66. timing critical
- [It is critical to come as close as possible to the requested time (e.g., for a through antimicrobial level). ( HL7V3.0 )] (UMLS (HL7) C1555333) =Temporal Concept =ActPriority;
|
- 17. Tibial Nerve
- [The medial terminal branch of the sciatic nerve. The tibial nerve fibers originate in lumbar and sacral spinal segments (L4 to S2). They supply motor and sensory innervation to parts of the calf and foot. ( MSH )] (UMLS (NCI) C0040186) =Body Part, Organ, or Organ Component ;
| - 67. Timing critical (do as near as possible to requested time)
- (UMLS (HL7) C0694725) =Temporal Concept ;
=Priority;
|
- 18. Tibial Vein
- (UMLS (NCI) C0447138) =Body Part, Organ, or Organ Component
| - 68. Timing critical (do as near as possible to requested time)
- (UMLS (HL7) C1549565) =Idea or Concept =Processing priority;
|
- 19. TIBIALIS TENDINITIS
- (UMLS (ICD9CM) C0158321) =Disease or Syndrome
| - 69. Timing/quantity
- (UMLS (HL7) C1547405) =Idea or Concept =Data type;
|
- 20. Tibolone
- [A synthetic anabolic steroid with potential menopausal symptoms suppressant activity. Tibolone exerts its effect mainly through its metabolites; its 3alpha- and 3beta-hydroxy metabolites selectively bind to and activate estrogenic receptors on bone and vaginal tissue leading to a decrease in bone turnover, improves bone density, and affects vaginal integrity and dryness, respectively; derived from the 3beta-hydroxy metabolite, its delta4-isomer activates androgenic receptors in the brain and liver as well as progestogenic receptors in endometrial tissue, thereby affecting sexual function, lipid metabolism, and endometrial functions, respectively. In breast and endometrial tissue, tibolone inhibits sulfatase, thereby preventing the conversion of estrone sulfate to estrone and inhibit 17beta-hydroxysteroid dehydrogenase activity, thereby inhibiting estradiol formation from androgens and reducing estrogen-mediated effects in breast and uterus. ( NCI )] (UMLS (NCI) C0076660) =Steroid; Pharmacologic Substance
| - 70. TimingDetectedIssueCode
- [Proposed therapy may be inappropriate or ineffective based on the proposed start or end time. ( HL7V3.0 )] (UMLS (HL7) C1698589) =Intellectual Product ;
=AdministrationDetectedIssueCode;
=Start Too Late Alert;
End Too Late Alert;
|
- 21. TIC DISORDER NOS
- [Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany general medical conditions. (From DSM-IV, 1994) ( MSH )] (UMLS (ICD9CM) C0040188) =Disease or Syndrome ;
=Dyscinesia;
movement disorder;
Mental Disorders Diagnosed in Childhood;
=Gilles de la Tourette's syndrome | - 71. TimingEvent
- (UMLS (HL7) C1553787) =Intellectual Product =CodeSystem;
=ACM;
AC;
PC;
IC;
ACT;
ACV;
PCM;
PCD;
PCV;
ICM;
ICD;
ICV;
HS;
|
- 22. TIC Regimen
- [A regimen consisting of paclitaxel, ifosfamide, mesna and carboplatin used as salvage therapy for the treatment of advanced-stage testicular cancer; also used for the treatment of unresectable and recurrent squamous cell head and neck cancer. ( NCI )] (UMLS (NCI) C0912478) =Therapeutic or Preventive Procedure ;
| - 72. TIMP
- [21-27 kDa proteins found in the extracellular matrix; regulate the activity of collagenase and therefore are important in tumorigenesis, angiogenesis, chondrosteosis, and other tissue forming processes. ( CSP )] (UMLS (NCI) C0145988) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =protease inhibitor;
|
- 23. Ticar
- (UMLS (NCI) C0699871) =Organic Chemical; Antibiotic
| - 73. TIMP1
- [This gene plays a role in the degradation of the extracellular matrix. It is also involved in the promotion of cell proliferation and inhibition of apoptosis. ( NCI )] (UMLS (NCI) C1367459) TIMP1 Gene;
Tissue Inhibitor of Metalloproteinase 1 (Erythroid Potentiating Activity, Collagenase Inhibitor) Gene =Gene or Genome |
- 24. TICARCILLIN
- [A broad-spectrum, semi-synthetic Penicillin antibiotic with bactericidal activity. Similar to carbenicillin in action, ticarcillin acylates C-terminal domain of penicillin-sensitive transpeptidase, resulting in opening the lactam ring of the antibiotic. This inactivation prevents the formation of the cross-linkage of peptidoglycan strands, thereby inhibiting the third and last stage of bacterial cell wall synthesis. As a result, cell wall integrity is compromised and cell lysis may follow. This agent usually is administered with a beta-lactamase inhibitor such as clavulanic acid. ( NCI )] (UMLS (NCI) C0040193) =Organic Chemical; Antibiotic =Penicillanic Acid;
[AM054] EXTENDED SPECTRUM PENICILLINS =Ticarcillin Disodium | - 74. TIMP2
- [This gene is involved in the degradation of the extracellular matrix. It also plays a role in the suppression of endothelial cell proliferation. ( NCI )] (UMLS (NCI) C1336629) TIMP2 Gene;
Tissue Inhibitor of Metalloproteinase 2 Gene =Gene or Genome ;
|
- 25. Ticarcillin Disodium
- [The disodium salt of ticarcillin, a broad-spectrum, semi-synthetic Penicillin antibiotic with bactericidal activity. Similar to carbenicillin in action, ticarcillin acylates C-terminal domain of penicillin-sensitive transpeptidase, resulting in opening the lactam ring of the antibiotic. This inactivation prevents the formation of the cross-linkage of peptidoglycan strands, thereby inhibiting the third and last stage of bacterial cell wall synthesis. As a result, cell wall integrity is compromised and cell lysis may follow. This agent usually is administered with a beta-lactamase inhibitor such as clavulanic acid. ( NCI )] (UMLS (NCI) C0546880) =Organic Chemical; Antibiotic ;
=TICARCILLIN;
=TICARCILLIN DISODIUM 3;
TICARCILLIN DISODIUM 3 GM/100ML;
TICARCILLIN DISODIUM 3 GM/VIL;
TICARCILLIN DISODIUM 30 MG/ML;
TICARCILLIN DISODIUM 40 MG/ML;
TICARCILLIN DISODIUM 20 GM/VIL;
TICARCILLIN DISODIUM 30 GM/VIL;
TICARCILLIN DISODIUM 1 GM/VIL;
| - 75. TIMP3
- [This gene plays a role in the degradation of the extracellular matrix. It is also involved in the induction of apoptosis and inhibition of angiogenesis. ( NCI )] (UMLS (NCI) C1336630) TIMP3 Gene;
Tissue Inhibitor of Metalloproteinase 3 (Sorsby Fundus Dystrophy, Pseudoinflammatory) Gene =Gene or Genome ;
|
- 26. Tick borne encephalitis virus
- [subgroup of genus Flavivirus causing encephalitis and hemorrhagic fevers; found in Europe and the former Soviet Union; transmitted by ticks and associated milk-borne transmission. ( CSP )] (UMLS (CSP) C0702091) =Virus ;
=Flaviviridae;
| - 76. Timunox
- (UMLS (NCI) C0918006) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
|
- 27. Tick-Born Hemorrhagic Fever
- (UMLS (NCI) C0343590) =Disease or Syndrome
| - 77. Tin
- [A lidded container made of thin sheet metal. ( HL7V3.0 )] (UMLS (HL7) C1553463) =Intellectual Product =MultiUseContainerEntityType;
|
- 28. tick-borne encephalitis
- [tick-borne encephalitis vaccine ( HL7V3.0 )] (UMLS (HL7) C0593408) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 78. TINCTURE
- [An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances. (NCI) ( NCI )] (UMLS (NCI) C0991583) Tincture Dosage Form;
Tincture Dose Form;
=Biomedical or Dental Material =Topical Solution;
|
- 29. TICK-BORNE FEVER
- (UMLS (ICD9CM) C0040199) =Disease or Syndrome ;
| - 79. TINEA BLANCA
- (UMLS (ICD9CM) C0040249) =Disease or Syndrome ;
|
- 30. TICK-BORNE RICKETTS NOS
- [ ] (UMLS (ICD9CM) C0153117) =Disease or Syndrome
| - 80. TINEA NIGRA
- (UMLS (ICD9CM) C0152067) =Disease or Syndrome
|
- 31. Ticlid
- (UMLS (NCI) C0733418) =Organic Chemical; Pharmacologic Substance
| - 81. Tingling
- [A sensation as of repetitive pin pricks, caused by cold or by striking a nerve, or as a result of various diseases of the central or peripheral nervous system. ( NCI )] (UMLS (NCI) C0423572) =Sign or Symptom
|
- 32. Ticlodix
- (UMLS (NCI) C0733419) =Organic Chemical; Pharmacologic Substance
| - 82. Tingling fingers/feet/toes
- (UMLS (ICPC) C0497290) (Tingling fingers/feet/toes; INURRIKETA,HATZAK/OINAK/ORTEJOAK; Prikken i haender/fodder/taeer; Tintelen vingers/voeten/tenen; SORMIEN/JALKATERIEN/VARPAIDEN PISTELY; Picotements doigts/pieds/orteils; Kribbeln der Finger, Fuesse, Zehen; raxishuyot (TINGLING) baetzbaot; kez-,labujj/lab zsibbadas; Formicolii di mani/piedi/dita; PRIKKING/PARESTESI HENDER/FOTTER; Formigueiros pes, dedos maos/pes; Hormigueo dedos, manos/pies; DOMNING I FINGRAR/FOTTER/TAR) =Sign or Symptom =neurologic; Symptoms and Complaints Component
|
- 33. Ticlodone
- (UMLS (NCI) C0733420) =Organic Chemical; Pharmacologic Substance
| - 83. Tinzaparin
- [The sodium salt of a low molecular weight heparin (LMWH) obtained by controlled enzymatic depolymerization of heparin from porcine intestinal mucosa with antithrombotic properties. Tinzaparin is a potent inhibitor of several activated coagulation factors, especially Factors Xa and IIa (thrombin); its primary activity is mediated through the plasma protease inhibitor antithrombin. In addition, this agent may inhibit angiogenesis through: 1) competitive binding of the heparin-binding sites on endothelial cells for the proangiogenic cytokines vascular endothelial growth factor (VEGF) and beta-fibroblast growth factor (beta-FGF) and 2) increasing the release of tissue factor pathway inhibitor (TFPI), a negative regulator of angiogenesis. ( NCI )] (UMLS (NCI) C0354599) =Carbohydrate; Pharmacologic Substance =tinzaparin;
=TINZAPARIN NA 20000 UNT/ML |
- 34. TICLOPIDINE
- [Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis. ( MSH )] (UMLS (NCI) C0040207) =Organic Chemical; Pharmacologic Substance =[BL700] PLATELET AGGREGATION INHIBITORS;
Thiophenes =5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridinium Chloride;
CLOPIDOGREL;
5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridinium Chloride | - 84. TIO TEF
- (UMLS (NCI) C0729090) Tio-tef;
=Organophosphorus Compound; Pharmacologic Substance; Hazardous or Poisonous Substance |
- 35. TICS OF ORGANIC ORIGIN
- [ ] (UMLS (ICD9CM) C0702141) =Pathologic Function ;
| - 85. TIOCONAZOLE
- [A synthetic imidazole derivative, fungicidal Terconazole inhibits cell wall synthesis by inhibiting the biosynthesis of ergosterol or other sterols, damaging the fungal cell membrane, altering its permeability, and promoting loss of essential intracellular elements. Tioconazole is active against Candida sp.. (NCI04) ( NCI )] (UMLS (NCI) C0076705) =Organic Chemical; Pharmacologic Substance =imidazole;
[GU300] ANTI-INFECTIVES, VAGINAL =TIOCONAZOLE 6.5 % |
- 36. TIETZE'S DISEASE
- [Idiopathic painful nonsuppurative swellings of one or more costal cartilages, especially of the second rib. The anterior chest pain may mimic that of coronary artery disease. (Dorland, 27th ed.) ( MSH )] (UMLS (ICD9CM) C0040213) =Disease or Syndrome ;
=Cartilage Diseases;
| - 86. Tiotrifar
- (UMLS (NCI) C0809913) =Organic Chemical; Pharmacologic Substance
|
- 37. TIF (trapping inhibition factor)
- [ ] (UMLS (CSP) C0598796) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 87. Tipifarnib/Topotecan
- (UMLS (NCI) C0879570) =Therapeutic or Preventive Procedure
|
- 38. TIFF Image
- [Although TIFF (Tag Image File Format) is an international standard it has many interoperability problems in practice. Too many different versions that are not handled by all software alike. ( HL7V3.0 )] (UMLS (HL7) C1554999) =Idea or Concept =ImageMediaType;
| - 88. Tipifarnib/Trastuzumab
- (UMLS (NCI) C0879522) =Therapeutic or Preventive Procedure ;
|
- 39. TIFF image data
- (UMLS (HL7) C1548462) =Intellectual Product ;
=Subtype of referenced data;
| - 89. Tipranavir
- (UMLS (NCI) C0663733) =Organic Chemical; Pharmacologic Substance ;
|
- 40. Tigason
- (UMLS (NCI) C0729231) =Organic Chemical; Pharmacologic Substance
| - 90. Tiratricol
- (UMLS (NCI) C0046882) =Organic Chemical; Pharmacologic Substance
|
- 41. TIGHT HYMENAL RING
- (UMLS (ICD9CM) C0156387) =Anatomical Abnormality
| - 91. Tirazone
- (UMLS (NCI) C0935950) =Organic Chemical; Pharmacologic Substance ;
|
- 42. TIL
- [Ubiquitously expressed (highest in spleen, ovary, leukocytes, thymus, and small intestine) by human TLR1 Gene (TLR family), 786-aa 90-kDa (precursor) type I transmembrane Toll-Like Receptor 1 contains a TIR domain and 8 LRR repeats and has a fundamental role in pathogen recognition and activation of innate immunity to microbial agents. Sharing structural and functional similarities, highly conserved TLRs recognize pathogen-associated molecular patterns expressed on infectious agents and mediate cytokine production necessary for effective immunity. TLR1 binds to the TLR2 extracellular domain and cooperates with TLR2. TLR1 appears to bind MyD88 via their TIR domains, and to TRAF6, leading to NF-Kappa-B activation, cytokine secretion, and inflammatory response. (NCI) ( NCI )] (UMLS (NCI) C0971363) TLR1;
TLR1 protein;
Toll/Interleukin-1 Receptor-Like;
Toll-Like Receptor 1;
=Amino Acid, Peptide, or Protein; Receptor ;
| - 92. Tire of Wheelchair
- (UMLS (NCI) C0184421) =Medical Device ;
|
- 43. TIL3
- [Highly expressed in ovary and myelomonocytic cells by human TLR5 Gene (TLR Family), 858-aa 98-kDa (precursor) type I membrane protein Toll-Like Receptor 5 contains a TIR domain and 15 LRR repeats. Mediating detection of bacterial flagellin (a virulence factor), TLR5 has a fundamental role in pathogen recognition and activation of innate immunity to microbial agents. Sharing structural and functional similarities, highly conserved TLRs recognize pathogen-associated molecular patterns expressed on infectious agents and mediate cytokine production necessary for effective immunity. Likely bound to MyD88 via the TIR domains, TLR5 acts via MyD88 and TRAF6, leading to NF-Kappa-B activation, TNF-alpha production, and the inflammatory response. (NCI) ( NCI )] (UMLS (NCI) C0966553) TLR5;
Toll/Interleukin-1 Receptor-Like Protein 3;
toll-5 receptor;
Toll-Like Receptor 5;
=Amino Acid, Peptide, or Protein; Receptor ;
| - 93. Tis
- (UMLS (NCI) C0475413) =Finding ;
|
- 44. TIL4
- [Highly expressed in monocytes, bone marrow, lymph node, and spleen by human TLR2 Gene (TLR Family), 784-aa 90-kDa (precursor) type I transmembrane Toll-Like Receptor 2 contains a TIR domain and 14 LRR repeats and has a fundamental role in pathogen recognition and activation of innate immunity. Sharing structural and functional similarities, TLRs recognize pathogen-associated molecular patterns expressed on infectious agents and mediate cytokine production for effective immunity. With LY96, TLR2 mediates response to microbial lipoproteins and cell wall components. Binding LY96 and TLR6 via the extracellular domains, TLR2 recognizes MALP-2, STF, PSM, and OspA-L with TLR6. TLR2 acts via MyD88 (via their TIR domains) and TRAF6, activating NF-Kappa-B, cytokine secretion, and inflammatory response. TLR2 may promote apoptosis in response to lipoproteins. (NCI) ( NCI )] (UMLS (NCI) C0754728) TLR2;
Toll/Interleukin 1 Receptor-Like 4;
Toll/Interleukin 1 Receptor-Like Protein 4;
Toll-Like Receptor 2;
toll-like receptor-2 =Amino Acid, Peptide, or Protein; Receptor ;
| - 94. TISSEEL
- (UMLS (NCI) C0947703) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 45. Tilade
- (UMLS (NCI) C0132098) =Organic Chemical; Pharmacologic Substance ;
| - 95. TISSEEL VH Kit
- (UMLS (NCI) C1135156) =Drug Delivery Device
|
- 46. Tilt tube coagulation time
- [Coagulation, Tilt tube ( HL7V3.0 )] (UMLS (HL7) C1553118) =Laboratory Procedure =ObservationMethod;
| - 96. Tissue
- (UMLS (HL7) C1547928) =Intellectual Product =Specimen Source Codes;
|
- 47. Tilt tube reptilase induced coagulation
- [Coagulation, Tilt tube reptilase induced ( HL7V3.0 )] (UMLS (HL7) C1553119) =Laboratory Procedure =ObservationMethod;
| - 97. tissue bank
- [A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body. ( NCI )] (UMLS (CSP) C0040278) =Manufactured Object; Health Care Related Organization ;
|
- 48. Tiludronate Disodium
- (UMLS (NCI) C0286030) =Organic Chemical; Pharmacologic Substance ;
=TILUDRONATE;
=TILUDRONATE DISODIUM 200 MG | - 98. tissue culture
- [Originally the maintenance and growth of pieces of explanted tissue (plant or animal) in culture away from the source organism. Now usually refers to the (much more frequently used) technique of cell culture, using cells dispersed from tissues or distant descendants of such cells. ( NCI )] (UMLS (CSP) C0040284) =Laboratory Procedure
|
- 49. Time
- (UMLS (HL7) C1547403) =Idea or Concept =Data type;
◊ (UMLS (HL7) C1548318) Idea or Concept Value type; | - 99. tissue culture as a substitute for animal testing
- [ ] (UMLS (CSP) C0597820) =Research Activity
|
- 50. time course of drug use
- [ ] (UMLS (CSP) C0872371) =Quantitative Concept ;
| - 100. Tissue diagnosis
- (UMLS (HL7) C1546905) =Classification =Diagnosis Classification;
|
home
